Next to Hp, LAMP1, SYNE2, and ANXA6 were selected in the analysis for high‐risk adenomas, and also LRG1, RBP4, and FN1 for the high‐risk adenomas and CRCs. This evidence concerns the gene RBP4 and adenoma.